StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$97.90+0.09 (+0.09%)

Close on Nov 19, 2026Market cap $6.15BP/E –Yield –

Kodiak Sciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Kodiak Sciences's free cash flow for the twelve months ending Jun 30, 2026 was -$159.90M. For fiscal 2025 it was -$136.51M. The highest annual figure on record is -$16.82M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$136.51M–
FY2024Dec 31, 2024-$117.69M–
FY2023Dec 31, 2023-$195.53M–
FY2022Dec 31, 2022-$243.48M–
FY2021Dec 31, 2021-$199.30M–
FY2020Dec 31, 2020-$87.24M–
FY2019Dec 31, 2019-$39.58M–
FY2018Dec 31, 2018-$29.11M–
FY2017Dec 31, 2017-$17.86M–
FY2016Dec 31, 2016-$16.82M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$46.59M–
Q1 FY2026Mar 31, 2026-$40.95M–
Q4 FY2025Dec 31, 2025-$39.42M–
Q3 FY2025Sep 30, 2025-$32.94M–
Q2 FY2025Jun 30, 2025-$34.81M–
Q1 FY2025Mar 31, 2025-$29.35M–
Q4 FY2024Dec 31, 2024-$30.19M–
Q3 FY2024Sep 30, 2024-$21.34M–
Q2 FY2024Jun 30, 2024-$26.54M–
Q1 FY2024Mar 31, 2024-$39.62M–
Q4 FY2023Dec 31, 2023-$59.72M–
Q3 FY2023Sep 30, 2023-$32.99M–
Q2 FY2023Jun 30, 2023-$43.43M–
Q1 FY2023Mar 31, 2023-$59.39M–
Q4 FY2022Dec 31, 2022-$58.14M–
Q3 FY2022Sep 30, 2022-$61.36M–
Q2 FY2022Jun 30, 2022-$63.37M–
Q1 FY2022Mar 31, 2022-$60.62M–
Q4 FY2021Dec 31, 2021-$67.47M–
Q3 FY2021Sep 30, 2021-$56.78M–
Q2 FY2021Jun 30, 2021-$39.20M–
Q1 FY2021Mar 31, 2021-$35.86M–
Q4 FY2020Dec 31, 2020-$28.98M–
Q3 FY2020Sep 30, 2020-$26.18M–
Q2 FY2020Jun 30, 2020-$13.97M–
Q1 FY2020Mar 31, 2020-$18.11M–
Q4 FY2019Dec 31, 2019-$11.45M–
Q3 FY2019Sep 30, 2019-$7.85M–
Q2 FY2019Jun 30, 2019-$13.07M–
Q1 FY2019Mar 31, 2019-$7.21M–
Q4 FY2018Dec 31, 2018-$8.36M–
Q3 FY2018Sep 30, 2018-$5.00M–
Q2 FY2018Jun 30, 2018-$4.49M–
Q1 FY2018Mar 31, 2018-$11.26M–
Q4 FY2017Dec 31, 2017-$4.95M–

More Kodiak Sciences figures

See a number that looks wrong?